Domingo-Gonzalez R, Prince O, Cooper A, Khader S
Microbiol Spectr. 2016; 4(5).
PMID: 27763255
PMC: 5205539.
DOI: 10.1128/microbiolspec.TBTB2-0018-2016.
Jin F, Nathan C, Radzioch D, Ding A
Infect Immun. 1998; 66(6):2447-52.
PMID: 9596701
PMC: 108223.
DOI: 10.1128/IAI.66.6.2447-2452.1998.
Ahn M, Siziopikou K, Plate J, Casey L, Silver M, Harris J
Cancer Immunol Immunother. 1997; 45(1):37-44.
PMID: 9353425
PMC: 11037664.
DOI: 10.1007/s002620050398.
Nagineni C, Detrick B, Hooks J
Clin Diagn Lab Immunol. 1994; 1(5):569-77.
PMID: 8556503
PMC: 368341.
DOI: 10.1128/cdli.1.5.569-577.1994.
Schreiber A, Frei K, Lichtensteiger W, Schlumpf M
Agents Actions. 1993; 39(3-4):166-73.
PMID: 8304244
DOI: 10.1007/BF01998970.
Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products.
Crestani B, Cornillet P, Dehoux M, Rolland C, Guenounou M, Aubier M
J Clin Invest. 1994; 94(2):731-40.
PMID: 8040328
PMC: 296153.
DOI: 10.1172/JCI117392.
Activation of interleukin-6 gene expression through the NF-kappa B transcription factor.
Libermann T, Baltimore D
Mol Cell Biol. 1990; 10(5):2327-34.
PMID: 2183031
PMC: 360580.
DOI: 10.1128/mcb.10.5.2327-2334.1990.
Elevated monocyte interleukin-6 (IL-6) production in immunosuppressed trauma patients. I. Role of Fc gamma RI cross-linking stimulation.
Szabo G, Kodys K
J Clin Immunol. 1991; 11(6):326-35.
PMID: 1837029
DOI: 10.1007/BF00918798.
Elevated monocyte interleukin-6 (IL-6) production in immunosppressed trauma patients. II. Downregulation by IL-4.
Szabo G, Kodys K
J Clin Immunol. 1991; 11(6):336-44.
PMID: 1761639
DOI: 10.1007/BF00918799.
Evidence for the involvement of interleukin 6 in experimental cancer cachexia.
STRASSMANN G, Fong M, KENNEY J, Jacob C
J Clin Invest. 1992; 89(5):1681-4.
PMID: 1569207
PMC: 443047.
DOI: 10.1172/JCI115767.
